Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,593,252
-
Share change
-
+16,593,162
-
Total reported value
-
$352,567,000
-
Price per share
-
$21.40
-
Number of holders
-
31
-
Value change
-
+$352,564,998
-
Number of buys
-
30
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q2 2021
As of 30 Jun 2021,
CYTEIR THERAPEUTICS INC - COM (CYTT) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,593,252 shares.
The largest 10 holders included
Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, FMR LLC, BAKER BROS. ADVISORS LP, Ally Bridge Group (NY) LLC, CAAS CAPITAL MANAGEMENT LP, ACUTA CAPITAL PARTNERS, LLC, and Sofinnova Investments, Inc..
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.